Date: 04/01/2016
Whitman Walker Health’s Megan Coleman appeared on Good Morning Washington on Thursday, March 31, 2016 to talk about HIV Pre-Exposure Prophylaxis (PrEP)
Click HERE or on the photo to view the video.
P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...
